Consort diagram for pilot study of pembrolizumab therapy in smoldering myeloma. AKI, acute kidney injury attributed to pembrolizumab; AST, aspartate aminotransferase elevation attributed to pembrolizumab; LFTs, liver function tests elevation attributed to pembrolizumab.